China’s NMPA Announces Good Practices for Review Timelines During the Drug Evaluation Process

China’s NMPA Announces Good Practice for Timing Termination and Restoration of Review in the Process of Drug Evaluation
China’s NMPA Announces Good Practice for Timing Termination and Restoration of Review in the Process of Drug Evaluation
Copyright ©2023 Global Regulatory Partners